2.1. Next-Generation Sequencing Reveals Different RNA Expression of Genes Related to Immune Response and Cell Cycle in IDH1-Mutant Glioblastoma Cells but not in IDH1-Wildtype Cells after Adding Bevacizumab to Temozolomide. This evidence concerns the gene IDH1 and glioblastoma.